• Number of new chemical or biological entities 2016 by region | Statistic

Health & Pharmaceuticals›
Pharmaceutical Products & Market›
Pharmaceutical industry - number of new substances 1992-2016

Premium

Number of new chemical or biological entities developed between 1992 and 2016, by region of origin
Exclusive Premium Statistic

Pharmaceutical industry - number of new substances 1992-2016

This statistic shows the number of new chemical or biological entities bought to the pharmaceutical industry in periods between 1992 and 2016, sorted by region. In the period between 1997 and 2001, 29 new substances were introduced through Japanese companies.

Show more

About this statistic

Show source

Download Settings Share

Chart type

Datalabels

Description Source More information

This statistic shows the number of new chemical or biological entities bought to the pharmaceutical industry in periods between 1992 and 2016, sorted by region. In the period between 1997 and 2001, 29 new substances were introduced through Japanese companies.

Show more

Show sources information; Show publisher information
Release date: June 2017

Region: Worldwide
Survey time period: 1997 to 2016
Supplementary notes: EFPIA stands for the European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several editions of this report.

More information

Other interesting statistics

2017 list of global top 10 biotech and pharmaceutical companies based on net income

2017 list of global top 10 biotech and pharmaceutical companies based on net income

2017 list of global top 10 biotech and pharmaceutical companies based on net income

Total global pharmaceutical R&D spending 2008-2022

Total global pharmaceutical R&D spending 2008-2022

Total global pharmaceutical R&D spending 2008-2022

World pharmaceutical sales 2015-2017 by region

World pharmaceutical sales 2015-2017 by region

World pharmaceutical sales 2015-2017 by region

Top therapeutic classes by global pharmaceutical sales 2017 estimates

Top therapeutic classes by global pharmaceutical sales 2017 estimates

Top therapeutic classes by global pharmaceutical sales 2017 estimates

Top 50 pharmaceutical companies - Rx sales and R&D spending 2016

Top 50 pharmaceutical companies - Rx sales and R&D spending 2016

Top 50 pharmaceutical companies - Rx sales and R&D spending 2016

Top 10 biotech and pharmaceutical companies based on market cap 2017

Top 10 biotech and pharmaceutical companies based on market cap 2017

Top 10 biotech and pharmaceutical companies based on market cap 2017

Statista Accounts: Access All Statistics. Starting from $588 / Year

Prices & Access

Statistics on "Global pharmaceutical industry"

Overview

The most important statistics

Revenue of the worldwide pharmaceutical market from 2001 to 2016 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2016
Distribution of global pharmaceutical market revenue from 2010 to 2016, by regionGlobal pharmaceutical market - revenue distribution 2010-2016 by region
Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*Top 10 global pharmaceutical markets: growth 2011-2016
Top 10 therapeutic classes by estimated global pharmaceutical sales in 2017 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2017 estimates
Global spending growth in selected pharmaceutical major therapeutic classes between 2012 and 2017*Spending growth of top pharmaceutical therapeutic classes by CAGR 2012-2017

Companies and products

The most important statistics

Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2016 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2016
2017 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2017 list of global top 10 biotech and pharmaceutical companies based on net income
Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2017 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2017
Top 15 pharmaceutical products by sales worldwide in 2017 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2017
Top generics manufacturers based on revenue in 2016 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2016
Top 10 cancer drugs worldwide by revenue in 2016 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2016
World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2016/2017Top pharmaceutical companies by capex growth in 2016/2017

Top companies by revenue

The most important statistics

Novartis AG's total revenue from 2007 to 2017 (in billion U.S. dollars)Novartis' revenue 2007-2017
Novartis AG's revenue from 2012 to 2017, by segment (in billion U.S. dollars)Novartis revenue 2012-2017 by segment
Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
Pfizer's revenue in 2014 and 2017, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2017
Total sales of the Roche Group from 2006 to 2017 (in million Swiss francs)Roche Group's total sales 2006-2017
Total sales of the Roche Group from 2013 to 2017, by division (in million Swiss francs)Roche Group's total sales by division 2013-2017

R&D, patents, new entities

The most important statistics

Total global spending on pharmaceutical research and development from 2008 to 2022 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2008-2022
Global top 10 pharmaceutical companies based on projected R&D spending in 2022 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2022
Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)Small molecules facing loss of developed market exclusivity 2011-2020
Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars)Top U.S. pharmaceutical patent expiries by revenue 2014-2016
Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
Reduction in value due to expiring patents in the United States from 2016 to 2019 (in billion U.S. dollars)*Value of expiring patents in U.S. 2016-2019
Number of new chemical or biological entities developed between 1992 and 2016, by region of originPharmaceutical industry - number of new substances 1992-2016
Projected distribution of global available new active substances by disease type between 1996 and 2020*Projection of new active substance distribution by disease 1996-2020

Outlook

The most important statistics

Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
Selected therapy areas in developed pharmaceutical markets by spending in 2020 (in billion U.S. dollars)*Select medicine spending classes in developed pharma markets 2020
Pharmaceutical spending per capita in selected countries as of 2017 (in U.S. dollars)*Pharmaceutical spending per capita in selected countries 2017
Global spending on medicines from 2010 to 2022 (in billion U.S. dollars)Global spending on medicines 2010-2022
Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
Projected expenditure on medicine of selected countries worldwide in 2022 (in billion U.S. dollars)Country spending on medicine 2022
Projected top 25 global pharmaceutical products by revenue in 2022 (in million U.S. dollars)Leading 25 global pharmaceutical products and respective revenues 2022

Related Studies: Available to Download in PDF or PPTX Format

Clinical trials

All Information
in one Presentation

Clinical trials

92 page/s
English
pptx
Detailed references

Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers

Statista for Your Company: The Research and Analysis Tool

Product Film
Statistics
Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Google

Samsung

Unilever

Procter and Gamble

Adobe

Telekom

PayPal

Otto

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Studies

Popular Related Keywords

Our Business Solutions: Save Time and Money

only

$588^*

per year

Your advantages

Full access to all our statistics
Download as XLS, PDF & PNG
Relevant data: complete source information

All functions of our platform illustrated face-to-face

Learn how Statista supports your company
Extensive tour across the whole portal
Personal guidance by our support team

Request webinar

The knowledge database for your company

All functions of the Premium Account
Access to dossiers, forecasts and studies
Access to our international database
Publishing rights and other exclusive functions

* All products require an annual contract.
Prices do not include sales tax
(New York residents only).

Statistics on the topic

Topics

About Statista

Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.

Internet & Telecommunications

Consumer Goods & FMCG

Retail & Trade

Travel, Tourism & Hospitality

Society

Transportation & Logistics

Learn more about how Statista can support your business.

Request webinar